Summary
Signal counts
Assets tracked: 3
Watchlist assets: 3
Registry stop assets: 1
Sponsor overview
Baylor Research Institute
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT00637117 | https://clinicaltrials.gov/study/NCT00313235 | https://clinicaltrials.gov/study/NCT06517212
Assets
Linked programs
- Autologous dendritic cells generated using GM-CSF, interferon alpha and LPS: Registry Stop Signal (4/5)
- DC Vaccine and Cyclophosphamide: Results Not Found Signal (2/5)
- Tirzepatide: Watchlist Signal (2/5)